What is the purpose of this trial?
The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.
Start Date: 03/20/2017
End Date: 04/30/2018
Last Updated: 02/22/2018
Study HIC#: 1610018578